In 2015, the U.S. Food and Drug Administration (FDA) made history by approving Flibanserin, the first treatment for female sexual dysfunction, specifically addressing hypoactive sexual desire disorder (HSDD) in premenopausal women. Marketed under the brand name Addyi. This medication provides an option for women experiencing distress due to low sexual...

Aging is a natural part of life that brings wisdom, experiences, and new perspectives. However, it is also true that with aging comes some negative aspects that many wouldn’t want to discuss, one of which is sexual vitality. Many men face the issue of erectile dysfunction, which is seen as...